209 related articles for article (PubMed ID: 17466303)
1. Reducing maternal mortality due to elective abortion: Potential impact of misoprostol in low-resource settings.
Harper CC; Blanchard K; Grossman D; Henderson JT; Darney PD
Int J Gynaecol Obstet; 2007 Jul; 98(1):66-9. PubMed ID: 17466303
[TBL] [Abstract][Full Text] [Related]
2. Misoprostol and women's health in Africa.
Okonofua F
Afr J Reprod Health; 2005 Apr; 9(1):7-9, 10-3. PubMed ID: 16104649
[No Abstract] [Full Text] [Related]
3. A risk reduction strategy to prevent maternal deaths associated with unsafe abortion.
Briozzo L; Vidiella G; Rodríguez F; Gorgoroso M; Faúndes A; Pons JE
Int J Gynaecol Obstet; 2006 Nov; 95(2):221-6. PubMed ID: 17010348
[TBL] [Abstract][Full Text] [Related]
4. Safe abortion information hotlines: An effective strategy for increasing women's access to safe abortions in Latin America.
Drovetta RI
Reprod Health Matters; 2015 May; 23(45):47-57. PubMed ID: 26278832
[TBL] [Abstract][Full Text] [Related]
5. [Legalized abortions reduced maternal mortality in South Africa. Morbidity and mortality before and after the change of legislation].
Bendz E; Liljequist VA; Bergström S
Lakartidningen; 2008 Oct 8-14; 105(41):2855-7. PubMed ID: 19009900
[No Abstract] [Full Text] [Related]
6. The use of misoprostol in termination of second-trimester pregnancy.
Lin CJ; Chien SC; Chen CP
Taiwan J Obstet Gynecol; 2011 Sep; 50(3):275-82. PubMed ID: 22030039
[TBL] [Abstract][Full Text] [Related]
7. Misoprostol priming prior to second trimester medical abortion.
Moreno-Ruiz NL; Vesona JL; Betstadt SJ; Feng KT; Borgatta L
Int J Gynaecol Obstet; 2009 Jul; 106(1):67-8. PubMed ID: 19358989
[No Abstract] [Full Text] [Related]
8. Acceptability and feasibility of medical abortion in Nepal.
Karki C; Pokharel H; Kushwaha A; Manandhar D; Bracken H; Winikoff B
Int J Gynaecol Obstet; 2009 Jul; 106(1):39-42. PubMed ID: 19345944
[TBL] [Abstract][Full Text] [Related]
9. Harm Reduction for Abortion in the United States.
Tasset J; Harris LH
Obstet Gynecol; 2018 Apr; 131(4):621-624. PubMed ID: 29528924
[TBL] [Abstract][Full Text] [Related]
10. Termination of pregnancy with misoprostol in the scarred uterus.
van Bogaert LJ
Int J Gynaecol Obstet; 2008 Jan; 100(1):80-1. PubMed ID: 17888919
[No Abstract] [Full Text] [Related]
11. How to manage unresponsiveness to misoprostol in failed second trimester pregnancy termination.
Pongsatha S; Tongsong T
J Obstet Gynaecol Res; 2013 Jan; 39(1):154-9. PubMed ID: 22691227
[TBL] [Abstract][Full Text] [Related]
12. [Randomized study of sulprostone versus misoprostol in the cervical preparation before elective abortion in nulliparous women].
Schaub B; Fuhrer P; Sainte-Rose D
J Gynecol Obstet Biol Reprod (Paris); 1995; 24(5):505-10. PubMed ID: 7499737
[TBL] [Abstract][Full Text] [Related]
13. Misoprostol and the debate over off-label drug use.
Weeks AD; Fiala C; Safar P
BJOG; 2005 Mar; 112(3):269-72. PubMed ID: 15713138
[No Abstract] [Full Text] [Related]
14. Midtrimester abortion using vaginal misoprostol for women with three or more prior cesarean deliveries.
Fawzy M; Abdel-Hady el-S
Int J Gynaecol Obstet; 2010 Jul; 110(1):50-2. PubMed ID: 20362989
[TBL] [Abstract][Full Text] [Related]
15. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
Ashok PW; Flett GM; Templeton A
Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
[TBL] [Abstract][Full Text] [Related]
16. Mifepristone-misoprostol midtrimester abortion: impact of gestational age on the induction-to-abortion interval.
Gómez O; Borrás A; Rabanal A; Palacio M; Carceller A; Coll O; Gratacós E
Contraception; 2010 Feb; 81(2):97-101. PubMed ID: 20103444
[TBL] [Abstract][Full Text] [Related]
17. The combination of mifepristone and misoprostol for the termination of pregnancy.
;
Int J Gynaecol Obstet; 2011 Oct; 115(1):1-4. PubMed ID: 21872858
[TBL] [Abstract][Full Text] [Related]
18. [Use of misoprostol in the termination of missed abortion].
Szymańska M; Suchońska B; Ziółkowska K; Bablok L
Med Wieku Rozwoj; 2003; 7(3 Suppl 1):307-12. PubMed ID: 15537276
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
Gatter M; Cleland K; Nucatola DL
Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
[TBL] [Abstract][Full Text] [Related]
20. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean.
Duley L
Br J Obstet Gynaecol; 1992 Jul; 99(7):547-53. PubMed ID: 1525093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
